ABCG2 and cancer: After heterodimerizing with RXR, the PPARγ/RXR complex binds to the PPAR response element upstream of the Abcg2 promotor, which induces drug resistance in cancer cells (Nakanishi and Ross, 2012; Fig. 6A).